Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Symptoms Associated With Menopause

Completed · Phase 3

Conditions studied: Vasomotor Symptoms Associated With Menopause

In brief

The purpose of this study is to determine whether bazedoxifene/conjugated estrogens combinations are effective in the treatment of moderate to severe vasomotor symptoms associated with menopause.

Key facts

Study ID

NCT00234819

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

People needed

325

Starts

2005-10-01

Expected to finish

2007-02-01

Last updated by the study team

2007-12-28

Who can join

Age: 40 and older, up to 64. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Generally healthy, postmenopausal women, aged 40 to 64, with last natural menstrual period completed at lease 6 months ago
• Intact uterus
• Seeking treatment for hot flushes and experiencing 7 moderate to severe hot flushes per day or 50 per week

You may not qualify if…

• History of active presence of thrombophlebitis, thrombosis, thromboembolic disorders
• History of active presence of stroke, TIA, heart attack or ischemic heart disease
• History of melanoma, breast or any gynecologic cancer at any time; history of any other cancer within the past 5 years

Where it is running

• Study site — Phoenix, Arizona, United States
• Study site — Fort Myers, Florida, United States
• Study site — North Port Richey, Florida, United States
• Study site — Scarborough, Maine, United States
• Study site — Albuquerque, New Mexico, United States
• Study site — Winston-Salem, North Carolina, United States
• Study site — Pottstown, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.